Your browser doesn't support javascript.
loading
The PERFUSE study: The experience of patients receiving Adalimumab biosimilar SB5.
Bouhnik, Yoram; Carbonnel, Franck; Fumery, Mathurin; Flamant, Mathurin; Buisson, Anne; Camoin, Armelle; Addison, Janet.
Afiliação
  • Bouhnik Y; Paris IBD Center, Groupe hospitalier privé Ambroise Paré - Hartmann, 25 Boulevard Victor Hugo, 92200 Neuilly sur Seine, France. Electronic address: yoram.bouhnik@institutdesmici.fr.
  • Carbonnel F; Hôpital Bicêtre, AP-HP, 78 Rue du Général Leclerc, 94270 Le Kremlin Bicêtre, France.
  • Fumery M; CHU Amiens, Département de Gastroentérologie, 1 Rond-point du Professeur Christian Cabrol, 80054 Amiens, France.
  • Flamant M; Clinique Jules Verne, Département de Gastroentérologie, 2-4 Route de Paris, 44300 Nantes, France.
  • Buisson A; AFA Crohn RCH, 32 rue de Cambrai, 75019 Paris, France.
  • Camoin A; Biogen France SAS, Gastroenterology & Rhumatologie, Biosimilars, 1 Passerelle des Reflets, 92400 Courbevoie, France.
  • Addison J; Biogen IDEC, Clinical Research, Biosimilars, Innovation House 70 Norden Road, Maidenhead, Berkshire SL6 4AY, United Kingdom.
Dig Liver Dis ; 55(12): 1658-1666, 2023 Dec.
Article em En | MEDLINE | ID: mdl-37308394
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Colite Ulcerativa / Doença de Crohn / Medicamentos Biossimilares Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Dig Liver Dis Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Colite Ulcerativa / Doença de Crohn / Medicamentos Biossimilares Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Dig Liver Dis Assunto da revista: GASTROENTEROLOGIA Ano de publicação: 2023 Tipo de documento: Article